The NICHD has a number of active FOAs, including Requests for Applications (RFAs), Program Announcements (PAs), PAs with special reviews (PARs), and Notices (NOTs) related to the neurosciences.

FOAs on which the NICHD is a primary sponsor

• PAR-08-249 Mechanisms of Adverse Drug Effects in Children (R03)
  
  
• PAR-08-248 Mechanisms of Adverse Drug Effects in Children (R01)
  
  
• PAR-08-216 Developmental Pharmacology (R21)
  
  
• PAR-08-215 Developmental Pharmacology (R03)
  
  
• PAR-08-207 Meetings, Conferences, and Networks for Research Partnerships to Improve Functional Outcomes (R13)
  
  
• PAR-08-138 Genetic Screens to Enhance Zebrafish Research (R01)
  
  
• PA-08-104 Adverse Outcomes of Assisted Reproductive Technologies (R01)
  
  
• PA-08-103 Adverse Outcomes of Assisted Reproductive Technologies (P01)
  
  
• PA-08-011 Genetic Susceptibility & Variability of Human Structural Birth Defects (R01)
  
  
• RFA-HD-08-003 Multi-Drug Combinations to Promote Neurological Recovery in Traumatic Brain Injury (R01)
  
  
• PA-07-419 Developmental Mechanisms of Structural Human Birth Defects (P01)
  
  
• PAR-08-215 Developmental Pharmacology (R01)
  
  
• RFA-HD-08-016 Intellectual and Developmental Disabilities Research Centers 2009 (P30)
  
  

FOAs on which the NICHD is a secondary sponsor

• PAR-08-139 Enhancing Zebrafish Research with Research Tools and Techniques (R01)
  
  
• PA-08-100 Mechanisms of Functional Recovery After Stroke (R21)
  
  
• PA-08-099 Mechanisms of Functional Recovery After Stroke (R01)
  
  
• PA-08-053 Nanoscience and Nanotechnology in Biology and Medicine (R21)
  
  
• PA-08-052 Nanoscience and Nanotechnology in Biology and Medicine (R01)
  
  
• PA-07-398 Understanding and Treating Generalized and Focal Dystonias(R21)
  
  
• PA-07-397 Understanding and Treating Generalized and Focal Dystonias(R01)
  
  
• PA-07-396 Advanced Tools and Technologies for Deep Brain Stimulation in Movement Disorders – SBIR (R43/R44)
  
  
• PA-07-393 Biology of Manual Therapies (R01)
  
  
• PA-07-389 Neurotechnology Research, Development, and Enhancement(SBIR [R43/R44])
  
  
• PAR-07-352  Bioengineering Research Partnerships (R01)
  
  
• PA-07-284 Shared Neurobiology of Autism and Fragile X Syndrome (R01)
  
  
• PA-07-279 Bioengineering Research Grants (R01)
  
  
• PA-07-222 Developmental Psychopharmacology (R21)
  
  
• PAR-07-161 Innovations in Biomedical Computational Science and Technology Initiative--STTR (R41/R42)
  
  
• PAR-07-160 Innovations in Biomedical Computational Science and Technology Initiative--SBIR (R43/R44)
  
  
• PAR-07-096 Collaborative Research for Molecular and Genomic Studies of Basic Behavior in Animal Models (R01)
  
  
• PA-07-085 Research on Autism and Autism Spectrum Disorders (R01)
  
  
• PA-07-084 Developmental Psychopharmacology (R01)
  
  
• PA-07-082 Mechanisms, Models, Measurement, & Management in Pain Research (R01)
  
  
• PA-07-035 Focal Cognitive Deficits in CNS Disorders (R21)
  
  
• PA-07-034 Focal Cognitive Deficits in CNS Disorders (R03)
  
  
• PA-07-033 Focal Cognitive Deficits in CNS Disorders (R01)
  
  
• NOT-NS-07-009 U.S.-Japan Brain Research Cooperative Program (BRCP) —U.S. Component
  
  
• PA-06-543 Mechanisms, Models, and Management in Pain Research (R03)
  
  
• PA-06-542 Mechanisms, Models, and Management in Pain Research (R21)
  
  
• PA-06-430 Shared Biology of Fragile X Syndrome and Autism (R21)
  
  
• PA-06-429 Shared Biology of Fragile X Syndrome and Autism (R03)
  
  
• PA-06-392 Research on Autism and Autism Spectrum Disorders (R21)
  
  
• PA-06-391 Research on Autism and Autism Spectrum Disorders (R03)
  
  
• PAR-06-312 Biology of Manual Therapies (R21)
  
  
• PA-06-278 Neurotechnology Research, Development and Enhancement(R21)
  
  
• PA-06-242 Aging Musculoskeletal and Skin Extracellular Matrix (R21)
  
  

In addition, the NICHD is also involved in the active FOAs related to the NIH Blueprint for Neuroscience Research.